An Open-Label Treatment Protocol to Provide Continued Elvucitabine Treatment
Clinical trial NCT00675844 · COMPLETED
Trial details
- NCT number
- NCT00675844
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-03-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.